Disc Medicine Files 8-K: Material Definitive Agreement
Ticker: IRON · Form: 8-K · Filed: Jan 24, 2025 · CIK: 1816736
| Field | Detail |
|---|---|
| Company | Disc Medicine, Inc. (IRON) |
| Form Type | 8-K |
| Filed Date | Jan 24, 2025 |
| Risk Level | medium |
| Pages | 7 |
| Reading Time | 8 min |
| Key Dollar Amounts | $0.0001, $55.00, $54.9999, $243.3 m |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, corporate-filing
TL;DR
Disc Medicine just signed a big deal, filing an 8-K. Details to follow.
AI Summary
On January 21, 2025, Disc Medicine, Inc. entered into a material definitive agreement. The company, formerly known as Gemini Therapeutics, Inc. and FS Development Corp., is incorporated in Delaware and operates in the pharmaceutical preparations sector. This filing is a current report under the Securities Exchange Act of 1934.
Why It Matters
This filing indicates a significant new agreement for Disc Medicine, Inc., which could impact its business operations and future financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood.
Key Players & Entities
- Disc Medicine, Inc. (company) — Registrant
- Gemini Therapeutics, Inc. (company) — Former Company Name
- FS Development Corp. (company) — Former Company Name
- January 21, 2025 (date) — Date of Earliest Event Reported
- Delaware (jurisdiction) — State of Incorporation
- 001-39438 (identifier) — Commission File Number
- 321 Arsenal Street, Suite 101, Watertown, Massachusetts 02472 (address) — Principal Executive Offices
FAQ
What is the nature of the material definitive agreement entered into by Disc Medicine, Inc. on January 21, 2025?
The filing does not specify the details of the material definitive agreement, only that one was entered into on January 21, 2025.
What was Disc Medicine, Inc. previously known as?
Disc Medicine, Inc. was formerly known as Gemini Therapeutics, Inc. and FS Development Corp.
In which state is Disc Medicine, Inc. incorporated?
Disc Medicine, Inc. is incorporated in Delaware.
What is the principal executive office address for Disc Medicine, Inc.?
The principal executive office address is 321 Arsenal Street, Suite 101, Watertown, Massachusetts 02472.
What is the Commission File Number for Disc Medicine, Inc.?
The Commission File Number for Disc Medicine, Inc. is 001-39438.
Filing Stats: 1,981 words · 8 min read · ~7 pages · Grade level 13.3 · Accepted 2025-01-24 16:09:56
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share IRON The Nasdaq Global Ma
- $55.00 — mon Stock") at a price to the public of $55.00 per share and (ii) pre-funded warrants
- $54.9999 — Warrants"), at a price to the public of $54.9999 per Pre-Funded Warrant, which represent
- $243.3 m — fering are expected to be approximately $243.3 million, which includes the proceeds from
Filing Documents
- d833002d8k.htm (8-K) — 39KB
- d833002dex11.htm (EX-1.1) — 185KB
- d833002dex41.htm (EX-4.1) — 78KB
- d833002dex51.htm (EX-5.1) — 10KB
- d833002dex991.htm (EX-99.1) — 9KB
- d833002dex992.htm (EX-99.2) — 10KB
- g833002dsp62.jpg (GRAPHIC) — 6KB
- g833002dsp64.jpg (GRAPHIC) — 7KB
- 0001193125-25-012211.txt ( ) — 561KB
- iron-20250121.xsd (EX-101.SCH) — 3KB
- iron-20250121_lab.xml (EX-101.LAB) — 18KB
- iron-20250121_pre.xml (EX-101.PRE) — 11KB
- d833002d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DISC MEDICINE, INC. Date: January 24, 2025 By: /s/ John Quisel Name: John Quisel, J.D., Ph.D. Title: Chief Executive Officer